Impact of COVID-19 on Patients Hospitalized With Deep Vein Thrombosis and/or Pulmonary Embolism: A Nationwide

Adrija Hajra1, Akshay Goel2, Aaqib H Malik2

  • 1Department of Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.

Insights

Coronavirus disease 2019 (COVID-19) patients with deep vein thrombosis (DVT) and pulmonary embolism (PE) had higher in-hospital mortality than flu patients. Risk factors for COVID-19-associated DVT/PE mortality include older age and certain chronic conditions.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Coronavirus disease 2019 (COVID-19) is linked to an increased risk of venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Understanding the comparative in-hospital outcomes of patients with DVT/PE and concurrent COVID-19 versus flu is crucial for clinical management.

Purpose of the Study:

  • To compare in-hospital outcomes for patients diagnosed with DVT and/or PE who have concurrent COVID-19 infection versus those with concurrent flu infection.

Main Methods:

  • Analysis of the National Inpatient Sample (2019-2020) to identify adult hospitalizations with DVT and/or PE.
  • Stratification of patients based on concomitant COVID-19 or flu infection.
  • 1:1 propensity score matching to compare outcomes between the two groups.

Main Results:

  • Higher incidence of cardiac arrest and inpatient mortality observed in the COVID-19 group compared to the flu group.
  • Increased incidence of cardiogenic shock noted in the flu group.
  • Independent predictors of mortality in COVID-19 patients with DVT/PE included advanced age, Hispanic ethnicity, diabetes, chronic kidney disease, arrhythmia, liver disease, coagulopathy, and rheumatologic diseases.

Conclusions:

  • COVID-19 patients with DVT and/or PE face a higher risk of in-hospital mortality and cardiac arrest compared to flu patients.
  • Specific demographic and comorbidity factors significantly predict mortality in COVID-19 patients with DVT/PE.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
25
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
24
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
19
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
24
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23